1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.2.1        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Organization Size

1.2.2        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Offering

1.2.3        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Application

1.2.4        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Clinical Indication

1.2.5        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By End User

1.2.6        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           In-Silico Trial Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Concerns Over Animal Welfare and Benefits

5.1.2        Insufficient Variable Patient Data and Limited Timescale

5.2         Market Restraints

5.2.1        Insufficient Variable Patient Data and Limited Timescale

5.3         Market Opportunities

5.3.1        Growing Applications of In-silico Trials in Radiology and Orthopedic Device Industry

5.4         Future Trends

5.4.1        Adoption of Artificial Intelligence in In-Silico Drug Discovery

5.5         Impact Analysis

6.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– North America Analysis

6.1         North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue Forecast and Analysis

7.           North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028– by Organization Size

7.1         Overview

7.2         North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, By Organization Size, 2020 & 2028 (%)

7.3         Large Organizations

7.3.1        Overview

7.3.2        Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Small and Medium Organizations

7.4.1        Overview

7.4.2        Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

8.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Offering

8.1         Overview

8.2         North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

8.3         Products

8.3.1        Overview

8.3.2        Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.4         Platforms

8.4.1        Overview

8.4.2        Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

8.5         Services

8.5.1        Overview

8.5.2        Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Application

9.1         Overview

9.2         North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

9.3         Product Design and Discovery

9.3.1        Overview

9.3.2        Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.4         Product Development

9.4.1        Overview

9.4.2        Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.5         Pre-Clinical Targeting

9.5.1        Overview

9.5.2        Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.6         Assessment of Drugs and Other Biomedical Products

9.6.1        Overview

9.6.2        Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

9.7         Others (Optimization and Market Access)

9.7.1        Overview

9.7.2        Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – Clinical Indication

10.1      Overview

10.2      North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

10.3      Cardiovascular Disease

10.3.1     Overview

10.3.2     Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.4      Neurodegenerative Disease

10.4.1     Overview

10.4.2     Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.5      Oncology

10.5.1     Overview

10.5.2     Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.6      Rare Diseases

10.6.1     Overview

10.6.2     Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.7      Metabolic Diseases

10.7.1     Overview

10.7.2     Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.8      Immune Based Diseases

10.8.1     Overview

10.8.2     Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.9      Infectious Diseases

10.9.1     Overview

10.9.2     Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

10.10   Others (Haematology, Diabetes, Dermatology)

10.10.1  Overview

10.10.2  Others (Haematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 – End User

11.1      Overview

11.2      North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

11.3      Pharmaceutical and Biotechnology Companies

11.3.1     Overview

11.3.2     Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.4      Medical Technology Companies

11.4.1     Overview

11.4.2     Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.5      Contract Research Organizations

11.5.1     Overview

11.5.2     Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

11.6      Others (Universities and Research Centres)

11.6.1     Overview

11.6.2     Others (Universities and Research Centres): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028  (US$ Million)

12.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 – Geographical Analysis

12.1      North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

12.1.1     Overview

12.1.2     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)

12.1.4     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)

12.1.5     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)

12.1.6     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)

12.1.7     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)

12.1.8     North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

12.1.8.1       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.1       Overview

12.1.8.1.2       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.3       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)

12.1.8.1.4       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)

12.1.8.1.5       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)

12.1.8.1.6       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)

12.1.8.1.7       US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)

12.1.8.2       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.1       Overview

12.1.8.2.2       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.3       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)

12.1.8.2.4       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)

12.1.8.2.5       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)

12.1.8.2.6       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)

12.1.8.2.7       Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)

12.1.8.3       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.1       Overview

12.1.8.3.2       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.3       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2019–2028 (US$ Million)

12.1.8.3.4       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering, 2019–2028 (US$ Million)

12.1.8.3.5       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application, 2019–2028 (US$ Million)

12.1.8.3.6       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication, 2019–2028 (US$ Million)

12.1.8.3.7       Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User, 2019–2028 (US$ Million)

13.        In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      InSilicoTrials Technologies

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Dassault Systèmes SE

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Certara Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Computational Life

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Ansys, Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Synopsys, Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Sensyne Health plc.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Phesi

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Tempus

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Cerner Corporation

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028  (USD Million)

Table 3.             North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 4.             North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 6.             US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 7.             US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 8.             US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          US In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Canada In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Offering– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Clinical Indication – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Mexico In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Organic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 22.          Inorganic Developments in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Table 23.          Glossary of Terms

LIST OF FIGURES

Figure 1.           In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation

Figure 2.           North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Overview

Figure 3.           Large Organizations Segment Held Largest Share of Organization Size Segment in In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market

Figure 4.           Canada is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, Industry Landscape

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           In-Silico Trial Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Organization Size, 2020 & 2028 (%)

Figure 11.        Large Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Small and Medium Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 14.        Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        Platforms: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        Services: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 18.        Product Design and Discovery: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Product Development: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Pre-Clinical Targeting: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Assessment of Drugs and Other Biomedical Products: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Others (Optimization and Market Access): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 24.        Cardiovascular Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Neurodegenerative Disease: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Oncology: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.        Rare Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        Metabolic Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.        Immune Based Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        Infectious Diseases: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        Others (Hematology, Diabetes, and Dermatology): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Share by Segment - 2020 & 2028 (%)

Figure 33.        Pharmaceutical and Biotechnology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        Medical Technology Companies: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35.        Contract Research Organizations: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.        Others (Universities and Research Centers): In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37.        North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Key Country – Revenue (2021) (US$ Million)

Figure 38.        North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)

Figure 39.        North America: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, by Country, 2021 & 2028 (%)

Figure 40.        US: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Canada: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Mexico: In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Growth Strategies in the In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market (%)